U.S. Equity Strategy: Several Indicators Suggest a Pullback Likely
Despite the bulls still being in control, we have several ongoing concerns and we cannot rule out the potential for a pullback. Below we highlight...
607 Views
MSCI ACWI, STOXX 600 Breaking Out, Adding Fuel for Further U.S. Equity Market Rally
In today’s report we reiterate our bullish U.S. investment thesis, recap significant technical levels across indexes, and highlight attractive...
750 Views
Human Longevity
At KIS capital we try to keep ourselves at the forefront of technology and innovation, attempting to identify which industries may blossom, and...
860 Views
Sirius (éť–ĺ› ç”źç‰©) Pre-IPO: Pipeline Prioritization and Competitor Updates
Sirius update note: SRSD107 broadened to seven FXI indications, SRSD216 Phase 3 pulled into H2 '27. Competitive field tightens across FXI, Lp(a)...
291 Views
Pre-IPO Sirius Therapeutics - The Pipeline and the Concerns Behind
SRSD107 and SRSD216 have blockbuster potential,but will face R&D failure risk and uncertainties in commercialization.Sirius' lack of commercialized...
290 Views